Scinovex
articleTop 1% cited

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)

American Heart Journal · 1997 · Vol. 134(1) · pp. 44–54
Robert M. CaliffKirkwood F. AdamsWilliam J. McKennaMihai GheorghiadeBarry F. UretskySteven E. McNultyHarald DariusKevin A. SchulmanFaı̈ez ZannadEileen HandbergF HarrellWilliam Bruce WheelerJordi Soler‐SolerK. Swedberg
Pulmonary Hypertension Research and TreatmentsHeart Failure Treatment and ManagementBlood Pressure and Hypertension StudiesMedicineHeart failureEjection fractionPulmonary wedge pressureDigoxinCardiologyInternal medicineClinical endpointRandomized controlled trialCardiac index

MeSH terms

AgedAngiographyAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsCardiac OutputCardiotonic AgentsCause of DeathDigoxinDiureticsFemaleHeart FailureHumansInfusions, IntravenousMaleMiddle Aged
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) · Scinovex